Krsnaa Diagnostics Posts Record Q2 Revenue of ₹2,710 Mn
Krsnaa Diagnostics Ltd. announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The company achieved its highest ever quarterly revenue of ₹2,710 million, a 32% year-over-year increase. Half-year revenue grew 27% to ₹5,065 million, driven by new projects and existing operations. EBITDA for Q2 FY27 was ₹719 million, with a margin of 27%. Profit After Tax (PAT) stood at ₹246 million for the quarter, with a PAT margin of 9%. The moderation in H1 FY27 PAT was attributed to upfront expenditure for the Rajasthan project. The retail business showed strong momentum, with revenue up 35% YoY. The company highlighted its expanding network of pathology and radiology centers and strategic focus on PPP projects and retail diagnostics.
Key Highlights
- Record Q2 FY27 revenue of ₹2,710 million, up 32% YoY.
- H1 FY27 revenue increased 27% to ₹5,065 million.
- Retail revenue grew 35% YoY, with patient volumes up 45%.
- PAT for Q2 FY27 was ₹246 million; H1 FY27 PAT moderated due to project expenditure.
- Company expanding PPP presence and retail diagnostics as growth engines.
Price Impact
More from KRSNAA